Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antitubercular Agents | 10 | 2018 | 52 | 1.800 |
Why?
|
| Appendicitis | 2 | 2020 | 62 | 1.420 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 7 | 2017 | 7 | 1.300 |
Why?
|
| Colon | 3 | 2018 | 496 | 1.280 |
Why?
|
| Diverticulitis, Colonic | 2 | 2018 | 11 | 1.150 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 9 | 2018 | 12 | 1.080 |
Why?
|
| Laparoscopy | 4 | 2019 | 754 | 0.870 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 243 | 0.840 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2019 | 31 | 0.700 |
Why?
|
| Gastrostomy | 1 | 2019 | 69 | 0.670 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2204 | 0.650 |
Why?
|
| Hospital Charges | 1 | 2018 | 29 | 0.630 |
Why?
|
| Hospitals, Pediatric | 2 | 2019 | 107 | 0.630 |
Why?
|
| Feces | 1 | 2018 | 320 | 0.550 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 182 | 0.540 |
Why?
|
| Diverticulosis, Colonic | 1 | 2015 | 2 | 0.530 |
Why?
|
| Knowledge | 1 | 2015 | 29 | 0.530 |
Why?
|
| New York | 5 | 2021 | 69 | 0.520 |
Why?
|
| Diverticulitis | 1 | 2014 | 9 | 0.510 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 2018 | 58 | 0.510 |
Why?
|
| HIV Infections | 5 | 2013 | 773 | 0.510 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2014 | 33 | 0.500 |
Why?
|
| Dietary Supplements | 1 | 2015 | 128 | 0.500 |
Why?
|
| Length of Stay | 1 | 2018 | 704 | 0.500 |
Why?
|
| Diverticulum, Colon | 1 | 2014 | 10 | 0.490 |
Why?
|
| Probiotics | 1 | 2015 | 81 | 0.490 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 120 | 0.490 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 45 | 0.490 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 34 | 0.480 |
Why?
|
| Pneumonia | 1 | 2016 | 179 | 0.480 |
Why?
|
| Intestinal Diseases | 1 | 2014 | 79 | 0.480 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 146 | 0.480 |
Why?
|
| Bacteria | 1 | 2018 | 449 | 0.480 |
Why?
|
| Veterans Health | 1 | 2013 | 15 | 0.470 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2017 | 186 | 0.470 |
Why?
|
| Child | 9 | 2021 | 6928 | 0.420 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 230 | 0.410 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 549 | 0.400 |
Why?
|
| Male | 25 | 2024 | 40992 | 0.400 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 459 | 0.400 |
Why?
|
| Surgeons | 1 | 2015 | 233 | 0.400 |
Why?
|
| Humans | 37 | 2024 | 86650 | 0.390 |
Why?
|
| Retrospective Studies | 13 | 2021 | 8476 | 0.380 |
Why?
|
| Female | 25 | 2024 | 44562 | 0.380 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2015 | 44 | 0.380 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2010 | 33 | 0.370 |
Why?
|
| Mammography | 1 | 2013 | 463 | 0.370 |
Why?
|
| Risk Factors | 9 | 2021 | 5416 | 0.360 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 395 | 0.350 |
Why?
|
| Obesity | 1 | 2016 | 964 | 0.340 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 938 | 0.310 |
Why?
|
| Logistic Models | 4 | 2020 | 1185 | 0.310 |
Why?
|
| Middle Aged | 17 | 2021 | 25027 | 0.310 |
Why?
|
| Child, Preschool | 5 | 2020 | 3612 | 0.280 |
Why?
|
| South Africa | 5 | 2017 | 60 | 0.280 |
Why?
|
| Infant | 4 | 2024 | 3048 | 0.270 |
Why?
|
| Herniorrhaphy | 2 | 2024 | 79 | 0.270 |
Why?
|
| Pediatrics | 2 | 2021 | 344 | 0.260 |
Why?
|
| Aged | 12 | 2021 | 18407 | 0.260 |
Why?
|
| Pandemics | 2 | 2021 | 737 | 0.250 |
Why?
|
| Colitis, Ulcerative | 3 | 2020 | 711 | 0.240 |
Why?
|
| Cohort Studies | 5 | 2021 | 2763 | 0.240 |
Why?
|
| Sputum | 4 | 2015 | 34 | 0.230 |
Why?
|
| Hernia, Inguinal | 1 | 2024 | 67 | 0.220 |
Why?
|
| Adolescent | 11 | 2020 | 8982 | 0.210 |
Why?
|
| Adult | 15 | 2021 | 25648 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2015 | 143 | 0.210 |
Why?
|
| Infant, Premature | 1 | 2024 | 290 | 0.210 |
Why?
|
| Hospitalization | 3 | 2020 | 851 | 0.200 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2021 | 5 | 0.200 |
Why?
|
| Emergency Shelter | 1 | 2020 | 2 | 0.190 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 45 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 999 | 0.190 |
Why?
|
| Trauma Centers | 1 | 2021 | 115 | 0.190 |
Why?
|
| Troponin | 1 | 2020 | 24 | 0.190 |
Why?
|
| Ileostomy | 1 | 2020 | 30 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 78 | 0.180 |
Why?
|
| Appendectomy | 1 | 2020 | 33 | 0.180 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 67 | 0.180 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2904 | 0.180 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 6511 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2021 | 239 | 0.180 |
Why?
|
| Young Adult | 10 | 2020 | 5976 | 0.180 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2019 | 23 | 0.170 |
Why?
|
| Colectomy | 1 | 2020 | 167 | 0.170 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 103 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2021 | 170 | 0.170 |
Why?
|
| Prognosis | 2 | 2018 | 3681 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2021 | 280 | 0.170 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 87 | 0.160 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 232 | 0.160 |
Why?
|
| Health Personnel | 2 | 2010 | 201 | 0.160 |
Why?
|
| Maryland | 1 | 2018 | 35 | 0.160 |
Why?
|
| Ribotyping | 1 | 2018 | 11 | 0.160 |
Why?
|
| Specialization | 1 | 2018 | 65 | 0.150 |
Why?
|
| Hospitals | 1 | 2020 | 294 | 0.150 |
Why?
|
| Emergencies | 1 | 2018 | 113 | 0.150 |
Why?
|
| Treatment Outcome | 6 | 2019 | 7982 | 0.150 |
Why?
|
| Competency-Based Education | 1 | 2017 | 35 | 0.150 |
Why?
|
| Cost of Illness | 1 | 2018 | 150 | 0.150 |
Why?
|
| Prospective Studies | 5 | 2016 | 4212 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 240 | 0.140 |
Why?
|
| Infant, Newborn | 2 | 2024 | 2380 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2018 | 136 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2017 | 201 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 372 | 0.140 |
Why?
|
| Colonoscopy | 2 | 2015 | 267 | 0.140 |
Why?
|
| Global Health | 2 | 2015 | 193 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2018 | 321 | 0.140 |
Why?
|
| Age Factors | 2 | 2024 | 1849 | 0.140 |
Why?
|
| Mycobacterium | 1 | 2015 | 17 | 0.140 |
Why?
|
| Recurrence | 2 | 2018 | 1139 | 0.130 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2015 | 18 | 0.130 |
Why?
|
| Colorectal Surgery | 1 | 2015 | 22 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 453 | 0.130 |
Why?
|
| Medical Audit | 1 | 2015 | 40 | 0.130 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2015 | 52 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2018 | 840 | 0.130 |
Why?
|
| Celecoxib | 1 | 2014 | 31 | 0.130 |
Why?
|
| Sulfones | 1 | 2014 | 43 | 0.130 |
Why?
|
| Hospital Mortality | 3 | 2021 | 350 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 413 | 0.120 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 48 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 100 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2017 | 482 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2018 | 816 | 0.120 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 17 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 182 | 0.120 |
Why?
|
| Morbidity | 1 | 2014 | 148 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2015 | 162 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 584 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2014 | 153 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 373 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2015 | 751 | 0.110 |
Why?
|
| Coinfection | 1 | 2013 | 58 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 692 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 191 | 0.110 |
Why?
|
| Pyridines | 1 | 2014 | 310 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2014 | 300 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2015 | 328 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1804 | 0.100 |
Why?
|
| Comorbidity | 1 | 2016 | 945 | 0.100 |
Why?
|
| Survival Rate | 2 | 2020 | 1864 | 0.100 |
Why?
|
| Pain | 1 | 2014 | 390 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2017 | 756 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2015 | 972 | 0.100 |
Why?
|
| Mastectomy | 1 | 2013 | 243 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1938 | 0.090 |
Why?
|
| Microbiota | 1 | 2015 | 382 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 64 | 0.090 |
Why?
|
| Time Factors | 2 | 2021 | 5215 | 0.090 |
Why?
|
| Drug Therapy, Combination | 3 | 2018 | 895 | 0.090 |
Why?
|
| Cross Infection | 1 | 2010 | 142 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 1169 | 0.090 |
Why?
|
| Mass Screening | 1 | 2013 | 619 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2017 | 1010 | 0.080 |
Why?
|
| Gestational Age | 1 | 2024 | 312 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 361 | 0.050 |
Why?
|
| Incidence | 2 | 2021 | 1578 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2021 | 93 | 0.050 |
Why?
|
| New York City | 1 | 2021 | 59 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2024 | 300 | 0.050 |
Why?
|
| Population Density | 1 | 2021 | 60 | 0.050 |
Why?
|
| Educational Status | 1 | 2021 | 190 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 114 | 0.050 |
Why?
|
| Poverty | 1 | 2021 | 173 | 0.040 |
Why?
|
| Orchiopexy | 1 | 2019 | 2 | 0.040 |
Why?
|
| Testicular Hydrocele | 1 | 2019 | 3 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 197 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 150 | 0.040 |
Why?
|
| United States | 2 | 2024 | 6674 | 0.040 |
Why?
|
| Capreomycin | 1 | 2018 | 1 | 0.040 |
Why?
|
| Clofazimine | 1 | 2018 | 1 | 0.040 |
Why?
|
| Diarylquinolines | 1 | 2018 | 1 | 0.040 |
Why?
|
| Kanamycin | 1 | 2018 | 4 | 0.040 |
Why?
|
| Amikacin | 1 | 2018 | 5 | 0.040 |
Why?
|
| Levofloxacin | 1 | 2018 | 7 | 0.040 |
Why?
|
| Linezolid | 1 | 2018 | 3 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 94 | 0.040 |
Why?
|
| Carbapenems | 1 | 2018 | 9 | 0.040 |
Why?
|
| Fluoroquinolones | 1 | 2018 | 22 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 300 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 679 | 0.040 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2019 | 74 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 286 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 141 | 0.040 |
Why?
|
| Russia | 1 | 2017 | 25 | 0.040 |
Why?
|
| Asia | 1 | 2017 | 95 | 0.040 |
Why?
|
| Motor Skills | 1 | 2017 | 71 | 0.040 |
Why?
|
| Simulation Training | 1 | 2017 | 88 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1672 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2015 | 39 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 156 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1722 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 68 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2261 | 0.030 |
Why?
|
| Ethionamide | 1 | 2013 | 1 | 0.030 |
Why?
|
| Ethambutol | 1 | 2013 | 6 | 0.030 |
Why?
|
| Pyrazinamide | 1 | 2013 | 5 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 860 | 0.030 |
Why?
|
| Cycloserine | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hypertension | 1 | 2021 | 1142 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3639 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 1163 | 0.030 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2010 | 30 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 861 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 797 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2014 | 502 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 567 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2015 | 731 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1239 | 0.020 |
Why?
|